TPH1 and rheumatoid arthritis: The work further highlights specific lymphocyte populations, including Tph cells, ABC, and activated B cells, that show both transcriptomic signatures of antigen activation and clonal expansion, marking these cell populations as promising therapeutic targets that might be selectively targeted to blunt the pathologic adaptive immune response in RA.